The Drug Policy Alliance is dedicated to making New Jersey a leader in drug policy reform. New Jersey's ineffective and counterproductive drug policies have increased the harms related to drug use and wasted taxpayer money. DPA advocates for effective drug policies based on science, compassion, health and human rights in New Jersey and around the country.
Unequal application of the law and other harms of marijuana prohibition affect millions of New Jerseyans every year. DPA led the campaign to pass legislation which created New Jersey’s medical marijuana program.
We are currently working on the New Solutions Marijuana Reform Campaign to legalize, tax and regulate marijuana like alcohol for adults in New Jersey.
DPA is working to reduce the harms associated with drug use and ineffective drug policies in New Jersey. Since 2003, we have successfully advocated for policies to prevent opioid overdose and expand access to life-saving sterile syringes that protect against HIV, hepatitis C, and other blood-borne diseases.
Our current priorities include expanding access to the opioid overdose antidote naloxone, supporting the growth of the syringe access programs in New Jersey, and preventing the spread of Hepatitis C.
Criminal Justice Reform
DPA created the New Solutions Campaign in 2008 in response to New Jersey’s then out of control prison growth. Since then, DPA has successfully led the advocacy efforts to pass both drug free zone reform and bail reform in New Jersey.
DPA continues to advocate under our New Solutions Campaign for policies that address the unacceptable and counterproductive consequences of mass criminalization in New Jersey.